NCT05094401View on ClinicalTrials.gov

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Type2 Diabetes
Interventions
DEVICE

BT-001

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.

Trial Locations (1)

75024

Catalyst Health Network, Plano

Sponsors
All Listed Sponsors
collaborator

Catalyst Health Network

UNKNOWN

lead

Better Therapeutics

INDUSTRY

NCT05094401 - Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter